Authors' Reply: Interpreting Agreement in AI-Assisted American Society of Anesthesiologists (ASA) Classification - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Authors’ Response: Understanding Agreement in AI-Assisted American Society of Anesthesiologists (ASA) Classification

  • By

  • Bo-Han Lin

  • Cheng-Wei Lu

  • I-Ching Hou

  • Tzu-Yu Lin

  • Chin-E Liu

  • Chong-Sun Khoi

  • October 21, 2026

Share

Clinical Scorecard: Authors’ Response: Understanding Agreement in AI-Assisted ASA Classification

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Authors’ Response
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationThe bootstrap analysis sampled 600 patients with replacement. Category-level cross-tabulations included 57 clinician-assigned ASA III patients and 6 clinician-assigned ASA IV patients in the NHI-data condition.
Care SettingRoutine preanesthetic documentation

Key Highlights

  • Unweighted Cohen κ was 0.883 (95% CI 0.841-0.946) with NHI data and 0.518 (95% CI 0.412-0.691) without NHI data.
  • The paired-bootstrap difference in unweighted κ was 0.365 (95% percentile bootstrap CI 0.292-0.440), based on 10,000 patient-level replicates.
  • Linearly weighted Cohen κ was 0.893 with NHI data and 0.560 without NHI data.
  • All 9 disagreements among 63 patients with NHI data were between adjacent ASA categories; without NHI data, 16 of 17 disagreements were adjacent.
  • The authors note that κ results do not establish comparable performance across ASA categories; interpretation is limited by the large proportion of ASA II patients and small ASA III-to-IV subgroups.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          The analysis involved 600 patients. Among clinician-assigned ASA III patients, AI classified 50 of 57 as ASA III with NHI data and 44 patients as ASA III without NHI data. Among clinician-assigned ASA IV patients, 4 of 6 were classified as ASA IV with NHI data and 2 of 6 without NHI data.

          No treatment or prescribing data are reported. The response evaluates classification agreement, not treatment effects.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content